NPS Pharmaceuticals (NPSP) Reports GATTEX Results, Said High Dose Did Not Reach Statistical Significance
Tweet Send to a Friend
NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) is lower after the company said twenty-five percent (25%) of patients receiving the higher dose ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


